Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine vs Ketamine for Emergence Agitation in Children
NCT05176119Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Mar 2021
- Primary completion
- Jun 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of nalbuphine and ketamine in Emergence agitation (EA) (3 arms), sponsored by Ain Shams University. Primary endpoint: Emergence Agitation at Extubation. Started Mar 2021; status: completed.
02
Drugs
nalbuphineketamine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT05176119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05176119.